At what level of hyperkalemia or creatinine elevation should ACE inhibitor therapy be stopped or not started?
Cleveland Clinic Journal of Medicine. 2001 September;68(9):754, 757-758, 760
September 1, 2001|Cleveland Clinic Journal of Medicine
Author and Disclosure Information
Saul Nurko, MD
Department of Nephrology and Hypertension, Cleveland Clinic
Address: Saul Nurko, MD, Department of Nephrology and Hypertension, A51, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; nurkos@ccf.org